Treatment of neovascular age-related macular degeneration: Current therapies
Albert J Augustin, Stefan Scholl, Janna KirchhofDepartment of Ophthalmology, Klinikum Karlsruhe, GermanyAbstract: Choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) is now the leading cause of blindness and severe vision loss among people over the age of 40 in the...
Guardado en:
Autores principales: | Albert J Augustin, Stefan Scholl, Janna Kirchhof |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/30772ebc671d418aaa9808f2565196a1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Radiation therapy for neovascular age-related macular degeneration
por: Robert Petrarca, et al.
Publicado: (2011) -
Treatment of neovascular age-related macular degeneration in patients with diabetes
por: Michael Cummings, et al.
Publicado: (2008) -
Current and emerging therapies for the treatment of age-related macular degeneration
por: M Vaughn Emerson, et al.
Publicado: (2008) -
Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration
por: Sobha Sivaprasad
Publicado: (2008) -
Age-related macular degeneration: current treatments
por: Jean Pierre Hubschman, et al.
Publicado: (2009)